Presentations to Emergency Departments for COPD: A Time Series Analysis.
Journal Information
Full Title: Can Respir J
Abbreviation: Can Respir J
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure This study is based in part on data provided by Alberta Health. The interpretation and conclusions contained herein are those of the researchers and do not necessarily represent the views of the Government of Alberta. Neither the government nor Alberta Health expresses any opinion in relation to this study. This study has not received funding. Sponsors have not had any role in the study. Dr. Rosychuk had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Competing Interests Dr. Rosychuk is salary-supported by Alberta Innovates-Health Solutions (AI-HS, Edmonton, Canada; formerly the Alberta Heritage Foundation for Medical Research) as a Health Scholar. Dr. Rowe's research is supported by a Tier 1 Canada Research Chair in Evidence-Based Emergency Medicine (Canadian Institutes of Health Research, Ottawa, Canada). In the past 3 years, Dr. Rowe has been involved in primary research funded by Merck, CEMPRA, and GlaxoSmithKline (GSK). He is not a member of any speaker's bureau or a paid consultant for any of these partners. The other authors declare no competing interests."
"Competing Interests: Dr. Rosychuk is salary-supported by Alberta Innovates-Health Solutions (AI-HS, Edmonton, Canada; formerly the Alberta Heritage Foundation for Medical Research) as a Health Scholar. Dr. Rowe's research is supported by a Tier 1 Canada Research Chair in Evidence-Based Emergency Medicine (Canadian Institutes of Health Research, Ottawa, Canada). In the past 3 years, Dr. Rowe has been involved in primary research funded by Merck, CEMPRA, and GlaxoSmithKline (GSK). He is not a member of any speaker's bureau or a paid consultant for any of these partners. The other authors declare no competing interests."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025